← Back to Search

Behavioral Intervention

Network Health Intervention for Suicide Prevention in Adolescents

N/A

Recruiting

Led By Ian Cero, PhD

Research Sponsored by University of Rochester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Youth subject is aged 12 - 18 at time of enrollment

Adult subject is at least 21 years of age

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 3 months post-treatment, approximately 6 months

Awards & highlights

Study Summary

This trial is testing a new suicide intervention for adolescents leaving psychiatric care. They want to see if it's feasible and acceptable, and if it actually reaches the people it's supposed to.

Who is the study for?

This trial is for adolescents aged 12-18 leaving acute psychiatric care who have had a suicide attempt or ideation in the past year. They must have a phone capable of texting and nominate an adult support team member over 21 with similar capabilities. Participants must speak English fluently, be able to contact their support weekly, and share their safety plan.Check my eligibility

What is being tested?

The study tests 'Acute Youth Connect', a network health intervention designed to help young people after they leave psychiatric care due to suicide-related issues. It aims to refine the program and evaluate its feasibility, acceptability, and effectiveness in engaging targets.See study design

What are the potential side effects?

Since this is not a drug trial but an intervention involving communication and support networks, typical medical side effects are not expected. However, there may be emotional or psychological impacts from participating in such interventions.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am between 12 and 18 years old.

Select...

I am 21 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 3 months post-treatment, approximately 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 3 months post-treatment, approximately 6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 3 months post-treatment, approximately 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Adult support team treatment completion

Interventional procedure

Text message responses

Secondary outcome measures

Change in weekly contact to supportive adults in their lives

Utilization of intervention content

Other outcome measures

Change in feelings of meaning

Change in feelings of purpose

Change in perceived social connectedness

+3 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Acute Youth Connect + TAUExperimental Treatment1 Intervention

Subjects will receive 12 weeks of post-discharge Acute Youth Connect intervention, in addition to regular post-discharge treatment as usual.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of RochesterLead Sponsor

836 Previous Clinical Trials

518,033 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,696 Previous Clinical Trials

6,952,519 Total Patients Enrolled

Ian Cero, PhDPrincipal InvestigatorUniversity of Rochester

Media Library

Acute Youth Connect (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05340296 — N/A

Suicide Attempt Research Study Groups: Acute Youth Connect + TAU

Suicide Attempt Clinical Trial 2023: Acute Youth Connect Highlights & Side Effects. Trial Name: NCT05340296 — N/A

Acute Youth Connect (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05340296 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any restrictions on my eligibility for participating in this experiment?

"This medical experiment is looking to enrol sixty adolescents with a history of parasuicide, aged 12-18. The following conditions must be met for consideration: having undergone care at the Child and Adolescent Partial Hospital Service (CAPHS) in the URMC Department of Psychiatry, endorsing suicidality during their stay at CAPHS as assessed on standardized intake questionnaire,, possessing an active cellular phone capable of sending/receiving SMS messages, no major mental health disorder impairing assent capacity, being fluent in English due to budget constraints., identifying two trusted adults not including parents or guardians,, ready to share suicide safety plan details, adult support"

Answered by AI

What is the current population size of participants in this research endeavor?

"Affirmative. Clinicaltrials.gov records show that this trial, which was initially listed on July 1st 2022, is currently in need of applicants. In total, 60 patients are desired from a single medical site."

Answered by AI

Is the age criteria for this research endeavor restricted to individuals over 40 years of age?

"Patients hoping to join this trial must be between 12 and 18 years old. This particular clinical study is amongst 57 trials targeting minors, while there are 117 studies for those over 65."

Answered by AI

Is this research protocol still accepting participants?

"Evidenced on the clinicaltrials.gov platform, this experimental study is accepting applications from prospective candidates. The trial was first posted online on July 1st 2022 and underwent its most recent edits on July 8th of the same year."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Network Health Intervention for Adolescents Leaving Acute Psychiatric Care

Ian Cero 2022. "Network Health Intervention for Adolescents Leaving Acute Psychiatric Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05340296.